The most clinically studied round embolic provides consistent and predictable results with proven success in uterine fibroid and prostate artery embolisation treatments.
Brings visibility to microsphere technology, combining coloured embolic particles with elemental gold for enhanced radiolucency.
Doxorubicin-loaded HepaSphere Microspheres have demonstrated success in the treatment of Hepatocellular Carcinoma (HCC) with high-objective tumour response with minimal impact to underlying healthy liver function.
Used for arteriovenous malformations, hypervascular tumours, and symptomatic uterine fibroids, these embolisation particles are more tightly calibrated for a more consistent size distribution than other nsPVA products.
Featuring tapered tips to facilitate smoother transitions, accordion hubs to minimise kinking, and a proprietary shaft to provide flexibility without compromising steerability.
Its exclusive swan neck design helps seat the catheter in the vessel, reducing the recoil effect and enhancing the delivery of flow-directed embolics.
Offers exceptional pushability and torqueability to facilitate precise navigation in challenging anatomy during embolisation procedures.